Universo Viviente
Related Articles
Paytm (One97 Communications)
| Low price 52 weeks | Current market price | % away from 52 week low |
|---|---|---|
| Rs.875 | Rs 906 | 3.47% |
Share One97 Communications, which is the parent company of Paytm, plunged from the IPO price of Rs 2,150 to the current price of Rs 906. Investors lost a lot of money if they received shares during of the IPO and still hold them. Several brokerages downgraded the stock to a sale. Although we do not wish to arrive at a valuation matrix, we continue to believe that almost all stocks are overvalued from space and some have posted losses. These actions should be avoided.
Political Bazaar (PB Fintech)
| Low price 52 weeks | Current market price | % away from 52 week low |
|---|---|---|
| Rs.778 | Rs 725 | 6.89% |
Like Paytm, investors in this IPO, who still own the shares attributed to the IPO, are sitting with losses. The IPO was priced at Rs 980 and the stock is currently at Rs 778, a reduction of almost 20%. We have not performed any analysis on this stock and do not intend to do so.
PB Fintech stock last traded at Rs 778.80 on the NSE.
Zomato
| Low price 52 weeks | Current market price | % away from 52 week low |
|---|---|---|
| Rs 84.50 | Rs88.00 | 5.00% |
This company is loss-making and reported a reduction in its net loss to Rs 63 crore for the quarter ending December 31, 2021, from a net loss of Rs 353 crore in the corresponding period last year.
Again, the stock has a Re 1 face value and so investors need to consider whether at a price of Rs 88 is a cheap price for a loss-making company.
Nykaa (FSN e-commerce companies)
| Low price 52 weeks | Current market price | % away from 52 week low |
|---|---|---|
| Rs 1571 | Rs 1640 | 4.89 |
This is a stock that has performed well for investors who received an allocation at the IPO price of Rs 1,125. The stock is not too far off its 52-week low. We think some of the stocks in the new age digital space are very expensive. Some of them are trading at ridiculously high prices compared to earnings multiples. We are not sure, if such an overexuberance in some of these stocks is justified.
While there may be some growth, stocks have passed their infection point. Unless investors start to see sustained earnings growth over the next 1-2 years, their patience could run out.
Warning
Investing in stocks presents a risk of financial loss. Investors should therefore exercise caution. Greynium Information Technologies and the author are not responsible for losses caused as a result of decisions based on the article.
